Mette Pinholt1,2, Sion C Bayliss3, Heidi Gumpert1, Peder Worning1, Veronika V S Jensen4, Michael Pedersen1,5, Edward J Feil3, Henrik Westh1,2. 1. Department of Clinical Microbiology, Hvidovre Hospital, Hvidovre, Denmark. 2. Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. 3. Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, Bath, UK. 4. Department of Clinical Microbiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. 5. Department of Clinical Microbiology, Herlev Hospital, Herlev, Denmark.
Abstract
OBJECTIVES: From 2012 to 2015, a sudden significant increase in vancomycin-resistant (vanA) Enterococcus faecium (VREfm) was observed in the Capital Region of Denmark. Clonal relatedness of VREfm and vancomycin-susceptible E. faecium (VSEfm) was investigated, transmission events between hospitals were identified and the pan-genome and plasmids from the largest VREfm clonal group were characterized. METHODS: WGS of 1058 E. faecium isolates was carried out on the Illumina platform to perform SNP analysis and to identify the pan-genome. One isolate was also sequenced on the PacBio platform to close the genome. Epidemiological data were collected from laboratory information systems. RESULTS: Phylogeny of 892 VREfm and 166 VSEfm revealed a polyclonal structure, with a single clonal group (ST80) accounting for 40% of the VREfm isolates. VREfm and VSEfm co-occurred within many clonal groups; however, no VSEfm were related to the dominant VREfm group. A similar vanA plasmid was identified in ≥99% of isolates belonging to the dominant group and 69% of the remaining VREfm. Ten plasmids were identified in the completed genome, and ∼29% of this genome consisted of dispensable accessory genes. The size of the pan-genome among isolates in the dominant group was 5905 genes. CONCLUSIONS: Most probably, VREfm emerged owing to importation of a successful VREfm clone which rapidly transmitted to the majority of hospitals in the region whilst simultaneously disseminating a vanA plasmid to pre-existing VSEfm. Acquisition of a heterogeneous accessory genome may account for the success of this clone by facilitating adaptation to new environmental challenges.
OBJECTIVES: From 2012 to 2015, a sudden significant increase in vancomycin-resistant (vanA) Enterococcus faecium (VREfm) was observed in the Capital Region of Denmark. Clonal relatedness of VREfm and vancomycin-susceptible E. faecium (VSEfm) was investigated, transmission events between hospitals were identified and the pan-genome and plasmids from the largest VREfm clonal group were characterized. METHODS: WGS of 1058 E. faecium isolates was carried out on the Illumina platform to perform SNP analysis and to identify the pan-genome. One isolate was also sequenced on the PacBio platform to close the genome. Epidemiological data were collected from laboratory information systems. RESULTS: Phylogeny of 892 VREfm and 166 VSEfm revealed a polyclonal structure, with a single clonal group (ST80) accounting for 40% of the VREfm isolates. VREfm and VSEfm co-occurred within many clonal groups; however, no VSEfm were related to the dominant VREfm group. A similar vanA plasmid was identified in ≥99% of isolates belonging to the dominant group and 69% of the remaining VREfm. Ten plasmids were identified in the completed genome, and ∼29% of this genome consisted of dispensable accessory genes. The size of the pan-genome among isolates in the dominant group was 5905 genes. CONCLUSIONS: Most probably, VREfm emerged owing to importation of a successful VREfm clone which rapidly transmitted to the majority of hospitals in the region whilst simultaneously disseminating a vanA plasmid to pre-existing VSEfm. Acquisition of a heterogeneous accessory genome may account for the success of this clone by facilitating adaptation to new environmental challenges.
Authors: Lena M Biehl; Paul G Higgins; Jannik Stemler; Meyke Gilles; Silke Peter; Daniela Dörfel; Wichard Vogel; Winfried V Kern; Hanna Gölz; Hartmut Bertz; Holger Rohde; Eva-Maria Klupp; Philippe Schafhausen; Jon Salmanton-García; Melanie Stecher; Julia Wille; Blasius Liss; Kyriaki Xanthopoulou; Janine Zweigner; Harald Seifert; Maria J G T Vehreschild Journal: Euro Surveill Date: 2022-01
Authors: Sarah A Egan; Nicole L Kavanagh; Anna C Shore; Sarah Mollerup; José A Samaniego Castruita; Brian O'Connell; Brenda A McManus; Grainne I Brennan; Mette Pinholt; Henrik Westh; David C Coleman Journal: J Antimicrob Chemother Date: 2022-02-02 Impact factor: 5.790
Authors: Lindsay A Rogers; Kayla Strong; Susan C Cork; Tim A McAllister; Karen Liljebjelke; Rahat Zaheer; Sylvia L Checkley Journal: Front Public Health Date: 2021-06-10
Authors: Anna Weber; Friederike Maechler; Frank Schwab; Petra Gastmeier; Axel Kola Journal: Antimicrob Resist Infect Control Date: 2020-07-16 Impact factor: 4.887
Authors: Sergio Arredondo-Alonso; Janetta Top; Jukka Corander; Rob J L Willems; Anita C Schürch Journal: Genome Med Date: 2021-01-20 Impact factor: 11.117